Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Regencell Bioscience (RGC)

Annual Return

Over the past 3 years, RGC has had an average annual return of +113.64%, outperforming the benchmark SPY, which returned +19.31% annual.

Over the past 5 years, RGC has had an average annual return of +84.65%, outperforming the benchmark SPY, which returned +12.55% annual.

Since Jul 16, 2021, RGC has had an average annual return of +78.87%, outperforming the benchmark SPY, which returned +12.95% annual.

202620252024202320222021
-75.71%+16,053.94%-52.95%-62.35%-12.44%+203.37%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+19%+4.96%-3.05%+14.90%-18.21%-74.52%-16.26%-75.71%
2025-23.08%+21.11%+592.72%+88.21%+1,361.72%-26.17%-22.54%+6.44%+9.96%+7.77%-30.75%+82.13%+16,053.94%
2024-24.65%-14.69%-33.34%+17.15%-10.82%-28.55%+186.68%-24.90%-23.33%+19.07%-4.26%-21.83%-52.95%
2023+3.27%-3.82%-6.56%+3.51%-19.11%+6.31%-18.97%-11.62%-13.64%+11.82%-31.96%-3.16%-62.35%
2022+9.89%+3.45%-40.90%+4.67%+34.45%+14.90%-7.55%-4.05%+3.58%-13.40%+12.57%-10.04%-12.44%
2021-12.67%+274.60%-34.05%-40.72%+88.04%+26.14%+203.37%

Drawdown analysis of Regencell Bioscience (RGC)

The maximum drawdown for the RGC was -93.87%, occurring on Jul 16, 2026. This drawdown has not yet recovered.

The current RGC drawdown is -93.46%.

Since Jul 16, 2021 RGC has experienced the following drawdowns:

  • 50% or more: 3 times
  • 40% or more: 3 times
  • 30% or more: 6 times
  • 20% or more: 8 times
  • 10% or more: 9 times
DepthStartTo BottomBottomTo RecoverEndTotal
-93.87%Jun 17, 2025270Jul 16, 2026OngoingOngoingOngoing
-93.09%Aug 25, 2021725Jul 16, 2024171Mar 21, 2025896
-59.87%Mar 21, 20258Apr 2, 202519Apr 30, 202527
-39.99%Jul 16, 202124Aug 19, 20211Aug 20, 202125
-33.58%May 12, 20251May 13, 20258May 23, 20259
-32.14%May 30, 202510Jun 13, 20251Jun 16, 202511
-28.28%Aug 20, 20211Aug 23, 20212Aug 25, 20213
-20.46%May 1, 20251May 2, 20251May 5, 20252
-10.42%May 23, 20251May 27, 20252May 29, 20253